1 "한국인 암등록 조사자료 분석고보서" 대한민국 보건복지부 1996
2 "이광수. 간절제술의 임상적 고찰. 대한외과학회지 1990" 325-332,
3 "원발성 간세포암종에 대한 절제술" 48 : 374-383, 1995
4 "송인성. 만성간염 및 간경변증 환자의 자연경과와 생존율에 관한 연구. 대한내과학회지 1994" 168-178,
5 "송인성. 간세포암종의 자연경과와 여러 치료방법에 따른 생존율에 관한 연구. 대한내과학회지 1993" 141-153,
6 "김수태. 간절제의 임상경험. 대한외과학회지 1986" 284-296,
7 "근치적 간절제술후 간세포암종의 예후 인자" 1 : 41-55, 1997
8 "간세포암종에서 수술 전 경도자 동맥 색전술의 임상적 의미" 59 : 585-590, 2000
9 "incidence estimation of primary liver cancer among Koreans. J Korea Cancer Association 1989" 241-,
10 "et al. Hepatic resection for hepatocellular carcinoma. World J Surg 1992" 97-105,
1 "한국인 암등록 조사자료 분석고보서" 대한민국 보건복지부 1996
2 "이광수. 간절제술의 임상적 고찰. 대한외과학회지 1990" 325-332,
3 "원발성 간세포암종에 대한 절제술" 48 : 374-383, 1995
4 "송인성. 만성간염 및 간경변증 환자의 자연경과와 생존율에 관한 연구. 대한내과학회지 1994" 168-178,
5 "송인성. 간세포암종의 자연경과와 여러 치료방법에 따른 생존율에 관한 연구. 대한내과학회지 1993" 141-153,
6 "김수태. 간절제의 임상경험. 대한외과학회지 1986" 284-296,
7 "근치적 간절제술후 간세포암종의 예후 인자" 1 : 41-55, 1997
8 "간세포암종에서 수술 전 경도자 동맥 색전술의 임상적 의미" 59 : 585-590, 2000
9 "incidence estimation of primary liver cancer among Koreans. J Korea Cancer Association 1989" 241-,
10 "et al. Hepatic resection for hepatocellular carcinoma. World J Surg 1992" 97-105,
11 "et al. Effect of diabetes mellitus on hepatic resection. Arch Surg 1993" 445-448,
12 "Wright R. Hepatic regeneration and metabolism after partial hepatectomy in diabetic rats effects of insulin therapy. Eur J Clin Invest 1986" 384-390,
13 "Way LW. Factors affecting the morbidity of elective liver resection. Am J Surg 1987" 189-196.
14 "Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation" 129 : 643-653, 1998
15 "Sundqvist K. Primary carcinoma of the liver improvement in sight" 54-60,
16 "Starzl TE. Personal experience with 411 hepatic resections. Ann Surg 1988" 421-434,
17 "Starzl TE. Experience with 150 liver resections. Ann Surg 1983" 247-253,
18 "Shoemaker WC. Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet 1978" 363-368,
19 "Shimazu M. Hepatic resection in 125 patients. Arch Surg 1984" 1025-1032,
20 "Secondary prevention of hepatocellular carcinoma" 10 : 683-690, 1995
21 "Schneider PD. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intrapentoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 1985" 210-218,
22 "Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma" 20 : 326-331, 1996
23 "Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma" 85 : 195-198, 1998
24 "Repeat hepatectomy for recurrent hepatocellular carcinoma" 83 : 127-131, 1996
25 "Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies" 20 : 77-80, 1996
26 "McClelland RN. Reduction in the morbidity and mortality of major hepatic resection. Experience with 52 patients Am J Surg 1982" 740-743,
27 "Levy J Transfusion-induced immunologic abnormalities not related to AIDS virus. N Engl J Med 1985 Nov 7" 1227-,
28 "Kakazu T. Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg 1994" 480-486,
29 "Jones RS. Hepatic resection for metastatic cancer. Ann Surg 1984" 182-186.
30 "Joishy SK. Hepatic resection. Pillars of success built on the foundation of 15 years of experience. Am J Surg 1981" 360-365,
31 "Intraperitoneal septic complications after hepatectomy. Ann Surg 1986" Kanematsu T 148-152,
32 "Hasegawa H. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989" 644-648,